| Marshall Colbert, CRNA | |
|
Christiana Care Health System, 4755 Ogletown Stanton Rd, Newark, DE 19718-0001 | |
| (302) 733-1000 | |
| Not Available |
| Full Name | Marshall Colbert |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 8 Years |
| Location | Christiana Care Health System, Newark, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043663289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | L6-0A00759 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bayhealth Medical Center, Inc | 1658364740 | 288 |
| Anesthesia Services Pa | 9537064498 | 188 |
News Archive
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
Helicos BioSciences Corporation announced today the introduction of a series of new single molecule sequencing kits and run configurations for the Helicos® Genetic Analysis System that will expand its versatility for customers. These new products and configurations, available without any System hardware upgrades, offer customers the ability to tailor parameters of the System to the specific application and number of samples under study.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
The risk of thyroid cancer rises with increasing radiation dose, according to the most thorough risk analysis for thyroid cancer to date among people who grew up in the shadow of the 1986 Chernobyl power-plant disaster.
› Verified 9 days ago
| Entity Name | Anesthesia Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053366377 PECOS PAC ID: 9537064498 Enrollment ID: O20031203000744 |
News Archive
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
Helicos BioSciences Corporation announced today the introduction of a series of new single molecule sequencing kits and run configurations for the Helicos® Genetic Analysis System that will expand its versatility for customers. These new products and configurations, available without any System hardware upgrades, offer customers the ability to tailor parameters of the System to the specific application and number of samples under study.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
The risk of thyroid cancer rises with increasing radiation dose, according to the most thorough risk analysis for thyroid cancer to date among people who grew up in the shadow of the 1986 Chernobyl power-plant disaster.
› Verified 9 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467546135 PECOS PAC ID: 1658364740 Enrollment ID: O20040405001600 |
News Archive
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
Helicos BioSciences Corporation announced today the introduction of a series of new single molecule sequencing kits and run configurations for the Helicos® Genetic Analysis System that will expand its versatility for customers. These new products and configurations, available without any System hardware upgrades, offer customers the ability to tailor parameters of the System to the specific application and number of samples under study.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
The risk of thyroid cancer rises with increasing radiation dose, according to the most thorough risk analysis for thyroid cancer to date among people who grew up in the shadow of the 1986 Chernobyl power-plant disaster.
› Verified 9 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1023006434 PECOS PAC ID: 1658364740 Enrollment ID: O20160527000094 |
News Archive
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
Helicos BioSciences Corporation announced today the introduction of a series of new single molecule sequencing kits and run configurations for the Helicos® Genetic Analysis System that will expand its versatility for customers. These new products and configurations, available without any System hardware upgrades, offer customers the ability to tailor parameters of the System to the specific application and number of samples under study.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
The risk of thyroid cancer rises with increasing radiation dose, according to the most thorough risk analysis for thyroid cancer to date among people who grew up in the shadow of the 1986 Chernobyl power-plant disaster.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marshall Colbert, CRNA 2 Reads Way Suite 201, Anesthesia Services, New Castle, DE 19720-1607 Ph: () - | Marshall Colbert, CRNA Christiana Care Health System, 4755 Ogletown Stanton Rd, Newark, DE 19718-0001 Ph: (302) 733-1000 |
News Archive
Though it would seem logical, cancer patients don't always choose therapies with the best chance for survival-cost and side effects are also major considerations. Little has been known about the extent to which cost and side effects influence a patient's treatment decision. Now, new findings by Fox Chase Cancer Center researchers reveals that a patient's socioeconomic status, more than any other characteristic-such as age or disease site-is predictive of whether he or she will favor high efficacy, low cost or low toxicity when choosing a treatment.
Helicos BioSciences Corporation announced today the introduction of a series of new single molecule sequencing kits and run configurations for the Helicos® Genetic Analysis System that will expand its versatility for customers. These new products and configurations, available without any System hardware upgrades, offer customers the ability to tailor parameters of the System to the specific application and number of samples under study.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents - most notably Novartis's Diovan - the hypertension drug market will experience only modest decline over the next decade.
The risk of thyroid cancer rises with increasing radiation dose, according to the most thorough risk analysis for thyroid cancer to date among people who grew up in the shadow of the 1986 Chernobyl power-plant disaster.
› Verified 9 days ago
Thomas P Knipper, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 111 Continental Dr, Newark, DE 19713 Phone: 302-709-4504 | |
Donte L Lang, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 111 Continental Dr, Suite 313, Newark, DE 19713 Phone: 302-709-4504 | |
Jennifer M. Bingnear, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Road, Newark, DE 19718 Phone: 302-733-1000 Fax: 302-733-2685 | |
Jason Michael Silovitch, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 732-986-5752 | |
Jeffrey Landau, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 111 Continental Dr, Newark, DE 19713 Phone: 302-709-4504 | |
Sean M Ogden, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 111 Continental Dr, Suite 412, Newark, DE 19713 Phone: 302-709-4497 Fax: 302-733-0854 |